Hypertension, H-type hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age= 18 years old; 2.A systolic blood pressure = 130 mmHg and/or a diastolic blood pressure = 80 mmHg measured in the office without taking antihypertensive medication; or is currently receiving antihypertensive medication; 3.Participate voluntarily in the study, understand the study procedures, and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Malignant diseases or end-stage diseases (such as end-stage heart failure, renal failure, advanced malignant tumors) with an expected survival period of less than 1 year; 2.The presence of severe cognitive impairment, mental illness, or other conditions that result in the inability to cooperate with the completion of basic follow-up or questionnaires; 3.It is planned to permanently move out of the area covered by the study within the next 2 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined major cardiovascular and cerebrovascular events: nonfatal myocardial infarction, nonfatal stroke, hospitalization for heart failure, and cardiovascular and cerebrovascular death.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Myocardial infarction;Patient-reported outcomes and behavioral-psychological indicators;Treatment adherence and health literacy;Multidimensional blood pressure assessment and control indicators;Subclinical target organ damage (cIMT, arterial stiffness, LVH, retinopathy);Serious adverse events, discontinuation rate due to adverse reactions, and neoplasms;Type 2 diabetes mellitus;Heart failure (hospitalization or emergency visit);Cardiovascular and cerebrovascular mortality;All-cause mortality;Stroke (subtyped: ischemic/hemorrhagic);Incremental Cost-Effectiveness Ratio (ICER);Progression of renal impairment (eGFR decline =40% or ESRD); | — |
Countries
China
Contacts
Peking University First Hospital